Literature DB >> 3281216

Kawasaki syndrome.

A H Rowley1, F Gonzalez-Crussi, S T Shulman.   

Abstract

Kawasaki syndrome is an acute self-limited illness of young children that may result in significant cardiovascular sequelae in 20% of patients. The etiology is unknown, but clinical and epidemiologic features strongly suggest an infectious etiology. The incidence of coronary artery abnormalities has been dramatically reduced by administration of intravenous gamma-globulin in the acute phase of illness. This paper reviews the clinical, laboratory, etiologic, epidemiologic, cardiovascular, pathologic, and therapeutic aspects of Kawasaki syndrome. Discovery of the etiology of this disorder will enable more specific diagnostic tests and therapies to be developed.

Entities:  

Mesh:

Year:  1988        PMID: 3281216     DOI: 10.1093/clinids/10.1.1

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  22 in total

Review 1.  The clinical efficacy of IVGG in Kawasaki disease.

Authors:  A H Rowley; S T Shulman
Journal:  Clin Rev Allergy       Date:  1992 Spring-Summer

2.  Cognitive and behaviour assessment following Kawasaki disease--a study from North India.

Authors:  P Nishad; Surjit Singh; M Sidhu; P Malhi
Journal:  Rheumatol Int       Date:  2009-08-02       Impact factor: 2.631

Review 3.  Kawasaki disease: recent advances.

Authors:  M Levin; E J Tizard; M J Dillon
Journal:  Arch Dis Child       Date:  1991-12       Impact factor: 3.791

4.  Sequence of the toxic shock syndrome toxin gene (tstH) borne by strains of Staphylococcus aureus isolated from patients with Kawasaki syndrome.

Authors:  R L Deresiewicz; J Flaxenburg; K Leng; D L Kasper
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

5.  Delayed diagnosis of Kawasaki disease presenting with massive lymphadenopathy and airway obstruction.

Authors:  D Burgner; M Festa; D Isaacs
Journal:  BMJ       Date:  1996-06-08

6.  Human herpesvirus 6 infection and Kawasaki disease.

Authors:  M Okano; J Luka; G M Thiele; Y Sakiyama; S Matsumoto; D T Purtilo
Journal:  J Clin Microbiol       Date:  1989-10       Impact factor: 5.948

7.  Cytokine modulation with immune gamma-globulin in peripheral blood of normal children and its implications in Kawasaki disease treatment.

Authors:  M Gupta; G J Noel; M Schaefer; D Friedman; J Bussel; R Johann-Liang
Journal:  J Clin Immunol       Date:  2001-05       Impact factor: 8.317

8.  Clinical aspects of 100 patients with Kawasaki disease.

Authors:  E J Tizard; A Suzuki; M Levin; M J Dillon
Journal:  Arch Dis Child       Date:  1991-02       Impact factor: 3.791

9.  Antiendothelial cell antibodies detected by a cellular based ELISA in Kawasaki disease.

Authors:  E J Tizard; E Baguley; G R Hughes; M J Dillon
Journal:  Arch Dis Child       Date:  1991-02       Impact factor: 3.791

10.  Inflammatory processes in Kawasaki disease reach their peak at the sixth day of fever onset: laboratory profiles according to duration of fever.

Authors:  Kyung-Yil Lee; Ji-Whan Han; Ja-Hyun Hong; Hyung-Shin Lee; Joon-Sung Lee; Kyung-Tai Whang
Journal:  J Korean Med Sci       Date:  2004-08       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.